Screening for retinopathy of prematurity in North China

Li Li1, Yanlin Gao1, Wei Chen1

  • 1Tianjin Eye Hospital, Tianjin Key Laboratory of Ophthalmology and Vision Science, Nankai University Eye Hospital, Clinical College of Ophthalmology, Tianjin Medical University, 4, Gansu Road, Heping District, Tianjin, 300020, People's Republic of China.

BMC Ophthalmology
|June 6, 2022
PubMed

Insights

Retinopathy of prematurity (ROP) affects 17.9% of premature infants in North China, with gestational age and birth weight being key risk factors. Modified screening criteria show improved effectiveness for ROP detection.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Early detection and treatment are crucial to prevent severe visual outcomes.

Purpose of the Study:

  • To determine the incidence and severity of ROP in North China.
  • To evaluate the efficacy of various ROP screening criteria.

Main Methods:

  • Retrospective analysis of ROP screening data from 2016-2021.
  • ROP grading followed the International Classification of Retinopathy of Prematurity (2005).
  • Evaluation of gestational age and birth weight as risk factors and comparison of different screening guidelines.

Main Results:

  • ROP was diagnosed in 17.9% of 4069 screened infants; 1.9% required treatment.
  • Lower gestational age and birth weight were significantly associated with ROP.
  • Current China, USA, and UK guidelines would miss 7.69%, 25.82%, and 14.29% of ROP cases, respectively.

Conclusions:

  • Gestational age and birth weight are primary risk factors for ROP.
  • Modified screening criteria (GA ≤ 33 weeks and/or BW ≤ 2100 g) significantly improved detection rates, missing only one case.
  • The incidence and treatment rates in Tianjin are comparable to other Chinese regions, suggesting localized screening modifications are beneficial.
Abstract

Related Concept Videos